Home LiteratureArticle Details
PMID: 11567075 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.

Chen BT, Rice ME

Abstract

Somatodendritic release of dopamine (DA) in midbrain represents a novel form of intercellular signaling that inherently differs from classic axon-terminal release. Here we report marked differences in the Ca(2+) dependence and time course of stimulated increases in extracellular DA concentration ([DA](o)) between the substantia nigra pars compacta (SNc) and striatum. Evoked [DA](o) was monitored with carbon-fiber microelectrodes and fast-scan cyclic voltammetry in brain slices. In striatum, pulse-train stimulation (10 Hz, 30 pulses) failed to evoke detectable [DA](o) in 0 or 0.5 mm Ca(2+) but elicited robust release in 1.5 mm Ca(2+). Release increased progressively in 2.0 and 2.4 mm Ca(2+). In sharp contrast, evoked [DA](o) in SNc was nearly half-maximal in 0 mm Ca(2+) and increased significantly in 0.5 mm Ca(2+). Surprisingly, somatodendritic release was maximal in 1.5 mm Ca(2+), with no change in 2.0 or 2.4 mm Ca(2+). Additionally, after single-pulse stimulation, evoked [DA](o) in striatum reached a maximum (t(max)) in <200 msec, whereas in SNc, [DA](o) continued to rise for 2-3 sec. Similarly, the time for [DA](o) to decay to 50% of maximum (t(50)) was 12-fold longer in SNc than striatum. A delayed t(max) in SNc compared with striatum persisted when DA uptake was inhibited by GBR-12909 and D(2) autoreceptors were blocked by sulpiride, although these agents eliminated the difference in t(50). Together, these data implicate different release mechanisms in striatum and SNc, with minimal Ca(2+) required to trigger prolonged DA release in SNc. Coupled with limited uptake, prolonged somatodendritic release would facilitate DA-mediated volume transmission in midbrain.

MeSH Terms
Animals Calcium/metabolism,pharmacology Carrier Proteins/metabolism Corpus Striatum/cytology,drug effects,metabolism Dendrites/drug effects,metabolism Dopamine/metabolism Dopamine Antagonists/pharmacology Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors/pharmacology Dose-Response Relationship, Drug Electric Stimulation Extracellular Space/metabolism Guinea Pigs In Vitro Techniques Male Membrane Glycoproteins Membrane Transport Proteins Nerve Tissue Proteins Neurons/drug effects,metabolism Reaction Time/drug effects Receptors, Dopamine D2 Substantia Nigra/cytology,drug effects,metabolism
Chemicals
Carrier Proteins Dopamine Antagonists Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors Membrane Glycoproteins Membrane Transport Proteins Nerve Tissue Proteins Receptors, Dopamine D2 Calcium Dopamine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Chen B T
Departments of Physiology and Neuroscience and Neurosurgery, New York University School of Medicine, New York, New York 10016, USA.
Rice M E
References (62)
62 references, click to expand
  1. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
    J Neurochem. 1995 Jul;65(1):192-200 PMID: 7790860
  2. Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake.
    J Neurophysiol. 2001 Apr;85(4):1761-71 PMID: 11287497
  3. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography.
    J Comp Neurol. 1991 Feb 15;304(3):419-34 PMID: 2022757
  4. Synaptic vesicles and exocytosis.
    Annu Rev Neurosci. 1994;17:219-46 PMID: 8210174
  5. Compartmentalization of the submembrane calcium activity during calcium influx and its significance in transmitter release.
    Biophys J. 1985 Sep;48(3):485-98 PMID: 2412607
  6. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.
    J Neurosci. 1997 Aug 1;17(15):5738-46 PMID: 9221772
  7. Dendritic release of dopamine in the substantia nigra.
    Nature. 1981 Feb 12;289(5798):537-42 PMID: 6258083
  8. Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra.
    Exp Brain Res. 1977 Nov 24;30(2-3):161-74 PMID: 598426
  9. Voltage-dependency of the dopamine transporter in the rat substantia nigra.
    Neurosci Lett. 1999 Jan 29;260(2):105-8 PMID: 10025710
  10. D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo.
    J Neurochem. 1993 Aug;61(2):764-7 PMID: 8336153
  11. Implications of all-or-none synaptic transmission and short-term depression beyond vesicle depletion: a computational study.
    J Neurosci. 2000 Feb 15;20(4):1575-88 PMID: 10662847
  12. Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro.
    Exp Brain Res. 1994;100(3):395-406 PMID: 7813678
  13. Distribution of dopamine-immunoreactive cell bodies in the guinea-pig brain.
    J Chem Neuroanat. 1990 Mar-Apr;3(2):101-23 PMID: 2340115
  14. Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum.
    Neuroscience. 1992 Nov;51(1):55-64 PMID: 1465186
  15. Release of dopamine from dendrites in rat substantia nigra.
    Nature. 1976 Mar 18;260(5548):258-60 PMID: 1256567
  16. Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata.
    J Physiol. 1998 Dec 15;513 ( Pt 3):805-17 PMID: 9824719
  17. Transmission at a central inhibitory synapse. III. Ultrastructure of physiologically identified and stained terminals.
    J Neurophysiol. 1982 Sep;48(3):708-36 PMID: 6290617
  18. Release of dopamine in vivo from cat substantia nigra.
    Nature. 1977 Mar 24;266(5600):375-7 PMID: 859606
  19. Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors.
    J Neurochem. 1993 Dec;61(6):2269-78 PMID: 8245977
  20. Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration.
    Neuroscience. 1981;6(11):2125-39 PMID: 6120482
  21. Profound neuronal plasticity in response to inactivation of the dopamine transporter.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4029-34 PMID: 9520487
  22. The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra.
    Rev Neurosci. 1997 Jan-Mar;8(1):55-76 PMID: 9402645
  23. Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones.
    J Physiol. 2000 Feb 15;523 Pt 1:163-73 PMID: 10673553
  24. The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus-secretion coupling.
    J Physiol. 1963 Jul;167(2):288-310 PMID: 16992152
  25. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy.
    Neuroscience. 1995 Apr;65(3):709-30 PMID: 7609871
  26. Ca2+ and secretory-vesicle dynamics.
    Trends Neurosci. 1995 Apr;18(4):191-6 PMID: 7778190
  27. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine.
    J Neurochem. 1989 Aug;53(2):652-4 PMID: 2568406
  28. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
    J Neurophysiol. 1997 Feb;77(2):863-73 PMID: 9065855
  29. The smooth endoplasmic reticulum as a possible storage site for dendritic dopamine in substantia nigra neurones.
    Experientia. 1979 Jan 15;35(1):101-3 PMID: 421770
  30. Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake.
    Neurosci Lett. 1994 Aug 1;176(2):259-63 PMID: 7830960
  31. Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects.
    Synapse. 1996 Aug;23(4):280-91 PMID: 8855513
  32. Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices.
    J Neurosci. 1998 May 15;18(10):3548-53 PMID: 9570786
  33. Reserpine-insensitive dopamine release in the substantia nigra?
    Brain Res. 1991 Aug 23;557(1-2):5-12 PMID: 1720998
  34. H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release.
    J Neurophysiol. 2001 Jun;85(6):2468-76 PMID: 11387393
  35. Co-administration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine.
    J Neurochem. 1993 Jan;60(1):376-9 PMID: 8417161
  36. Co-operative action a calcium ions in transmitter release at the neuromuscular junction.
    J Physiol. 1967 Nov;193(2):419-32 PMID: 6065887
  37. Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections.
    Exp Brain Res. 1983;49(2):209-17 PMID: 6832258
  38. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.
    J Neurosci. 1996 Jul 1;16(13):4135-45 PMID: 8753875
  39. Substantia nigra dopamine neurons: separate populations project to neostriatum and allocortex.
    Neurosci Lett. 1978 Feb;7(2-3):157-62 PMID: 19605105
  40. Distinct regional differences in dopamine-mediated volume transmission.
    Prog Brain Res. 2000;125:277-90 PMID: 11098664
  41. Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata.
    J Neurosci. 1998 Mar 15;18(6):2009-16 PMID: 9482788
  42. Quantal release of neurotransmitter and long-term potentiation.
    Cell. 1993 Jan;72 Suppl:55-63 PMID: 8094037
  43. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat.
    Neurochem Int. 1992 Mar;20 Suppl:107S-110S PMID: 1365406
  44. A quantitative comparison on the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of re-uptake in the caudate putamen and nucleus accumbens in the rat brain slice.
    Brain Res. 1994 Sep 19;657(1-2):42-50 PMID: 7820642
  45. The dopamine transporter: immunochemical characterization and localization in brain.
    J Neurosci. 1995 Mar;15(3 Pt 1):1714-23 PMID: 7534339
  46. Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms.
    Trends Pharmacol Sci. 1988 Aug;9(8):274-6 PMID: 2907952
  47. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets.
    J Neurosci. 1994 Jan;14(1):88-106 PMID: 7904306
  48. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro.
    J Neurophysiol. 1997 Feb;77(2):853-62 PMID: 9065854
  49. Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine.
    J Neurosci Methods. 2000 Aug 15;101(1):75-83 PMID: 10967364
  50. Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study.
    J Pharmacol Exp Ther. 1999 Apr;289(1):455-63 PMID: 10087038
  51. Diffusion characteristics and extracellular volume fraction during normoxia and hypoxia in slices of rat neostriatum.
    J Neurophysiol. 1991 Feb;65(2):264-72 PMID: 2016641
  52. Dependence of dopamine calibration factors on media Ca2+ and Mg2+ at carbon-fiber microelectrodes used with fast-scan cyclic voltammetry.
    J Neurosci Methods. 1998 Oct 1;84(1-2):55-62 PMID: 9821634
  53. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals.
    Synapse. 1997 Jun;26(2):194-8 PMID: 9131778
  54. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.
    J Neurosci. 1996 Jan 15;16(2):436-47 PMID: 8551328
  55. Interactions of presynaptic Ca2+ channels and snare proteins in neurotransmitter release.
    Ann N Y Acad Sci. 1999 Apr 30;868:144-59 PMID: 10414292
  56. Application of fast cyclic voltammetry to measurement of electrically evoked dopamine overflow from brain slices in vitro.
    J Neurosci Methods. 1990 Apr;32(1):37-44 PMID: 2139913
  57. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons.
    Nature. 2001 May 31;411(6837):583-7 PMID: 11385572
  58. Coupled oscillator model of the dopaminergic neuron of the substantia nigra.
    J Neurophysiol. 2000 May;83(5):3084-100 PMID: 10805703
  59. Dopamine transporter immunoreactivity in rat brain.
    J Comp Neurol. 1995 Aug 21;359(2):340-9 PMID: 7499533
  60. Dopamine D1 receptors facilitate transmitter release.
    Nature. 1993 Nov 25;366(6453):344-7 PMID: 8247128
  61. Comparison of somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens.
    Neuroscience. 1996 Feb;70(4):1025-37 PMID: 8848165
  62. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms.
    J Neurosci. 1989 Sep;9(9):3326-31 PMID: 2795165
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2001-10-01
Pages
7841-7
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6762877
Subset
IM
Grants
NINDS NIH HHS · NS-36362 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com